Sight Sciences, Inc. Common Stock (SGHT)

Price$4.45

Value ScoreC

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-54.70%

Price vs S&P 500 (4W)-17.28%

VGM Score48.51

Market Capitalization$242.12M

All Metrics

Book Value / Share (Quarterly)$1.00

P/TBV (Annual)0.94x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.74%

Cash Flow / Share (Quarterly)$-0.47

Price vs S&P 500 (YTD)-52.04%

Gross Margin (TTM)86.92%

Net Profit Margin (TTM)-46.83%

EPS (TTM)$-0.71

10-Day Avg Trading Volume0.14M

EPS Excl Extra (TTM)$-0.71

Revenue Growth (5Y)22.86%

EPS (Annual)$-0.74

ROI (Annual)-36.86%

Gross Margin (Annual)86.95%

Net Profit Margin (5Y Avg)-86.44%

Cash / Share (Quarterly)$1.57

Revenue Growth QoQ (YoY)12.51%

ROA (Last FY)-33.33%

Revenue Growth TTM (YoY)1.85%

EBITD / Share (TTM)$-0.67

ROE (5Y Avg)-49.23%

Operating Margin (TTM)-44.82%

Cash Flow / Share (Annual)$-0.56

P/B Ratio4.49x

P/B Ratio (Quarterly)3.78x

Net Income / Employee (Annual)$-206,600

EV / Revenue (TTM)2.49x

Net Interest Coverage (TTM)-31.86x

ROA (TTM)-32.17%

EPS Incl Extra (Annual)$-0.74

Current Ratio (Annual)10.22x

Quick Ratio (Quarterly)5.26x

3-Month Avg Trading Volume0.29M

52-Week Price Return5.95%

Revenue / Employee (TTM)$427,700

Tangible BV / Share (Quarterly)$2.61

P/S Ratio (Annual)3.13x

Asset Turnover (Annual)0.67x

52-Week High$9.24

Operating Margin (5Y Avg)-81.44%

EPS Excl Extra (Annual)$-0.74

CapEx CAGR (5Y)-25.10%

26-Week Price Return-46.77%

Quick Ratio (Annual)9.22x

13-Week Price Return12.37%

Total Debt / Equity (Annual)0.63x

Current Ratio (Quarterly)5.86x

Enterprise Value$197.70M

Revenue / Share Growth (5Y)19.32%

Asset Turnover (TTM)0.69x

Revenue / Employee (Annual)$415,900

Inventory Turnover (Annual)1.43x

Pretax Margin (Annual)-49.66%

Cash / Share (Annual)$1.72

3-Month Return Std Dev96.62%

Gross Margin (5Y Avg)84.57%

Net Income / Employee (TTM)$-200,300

ROE (Last FY)-60.10%

Net Interest Coverage (Annual)-22.57x

EPS Basic Excl Extra (Annual)$-0.74

Receivables Turnover (TTM)7.95x

Total Debt / Equity (Quarterly)0.75x

EPS Incl Extra (TTM)$-0.71

Receivables Turnover (Annual)7.54x

ROI (TTM)-36.09%

P/S Ratio (TTM)3.04x

Pretax Margin (5Y Avg)-86.26%

Revenue / Share (Annual)$1.48

Tangible BV / Share (Annual)$3.31

Price vs S&P 500 (52W)-18.41%

Year-to-Date Return-43.88%

5-Day Price Return-1.98%

EPS Normalized (Annual)$-0.74

ROA (5Y Avg)-33.13%

Net Profit Margin (Annual)-49.67%

Month-to-Date Return-8.44%

Cash Flow / Share (TTM)$-1.26

EBITD / Share (Annual)$-0.70

Operating Margin (Annual)-47.95%

LT Debt / Equity (Annual)0.63x

ROI (5Y Avg)-36.37%

LT Debt / Equity (Quarterly)0.68x

EPS Basic Excl Extra (TTM)$-0.71

P/TBV (Quarterly)1.19x

P/B Ratio (Annual)6.56x

Inventory Turnover (TTM)1.62x

Pretax Margin (TTM)-46.85%

Book Value / Share (Annual)$1.20

Price vs S&P 500 (13W)4.12%

Beta2.45x

Revenue / Share (TTM)$1.47

ROE (TTM)-59.10%

52-Week Low$3.11

vGradeC

gGradeC

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.24est. -0.17

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
SGHTSight Sciences, Inc. Common Stock	C	C	D	$4.45
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

Sight Sciences develops surgical and nonsurgical medical devices for treating eye diseases. The company's lead product, the OMNI Surgical System, treats primary open-angle glaucoma through minimally invasive canaloplasty and trabeculotomy using a single corneal incision. The company also markets the TearCare System for dry eye treatment, with glaucoma products generating the majority of revenue.